Ximluci
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ximluci, covering 2024-03-26 to 2024-03-26. Get the full timeline:
Most recent: EMA Authorised: Ximluci (ranibizumab) — STADA Arzneimittel AG
1 regulatory and trial event tracked for Ximluci, covering 2024-03-26 to 2024-03-26. Get the full timeline:
Most recent: EMA Authorised: Ximluci (ranibizumab) — STADA Arzneimittel AG